Multiple Assemblies exist for SMTL entry 3faa
Crystal structure of TGFbRI complexed with a 2-aminoimidazole inhibitor; X-RAY DIFFRACTION 3.35 Å

	SMTL ID 3faa.1 Ligands N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide; PHOSPHATE ION Polypeptides TGF-beta receptor type-1 Oligo-state monomer
	SMTL ID 3faa.2 Ligands N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide; PHOSPHATE ION Polypeptides TGF-beta receptor type-1 Oligo-state monomer
	SMTL ID 3faa.3 Ligands N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide; PHOSPHATE ION Polypeptides TGF-beta receptor type-1 Oligo-state monomer
	SMTL ID 3faa.4 Ligands N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide; PHOSPHATE ION Polypeptides TGF-beta receptor type-1 Oligo-state monomer
	SMTL ID 3faa.5 Ligands N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide; PHOSPHATE ION Polypeptides TGF-beta receptor type-1 Oligo-state monomer